Showing results (401-410 of 443) with videos related to
Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.Journal of Translational Medicine|August 5, 2020
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinomaXiaoyu Liu, Fang Gao, Longwei Jiang, et al.Bioconjugate Chemistry|August 22, 2024
Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled NanobodiesFalguni Basuli, Jianfeng Shi, Eric Lindberg, et al.Biorxiv : the Preprint Server for Biology|May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid TumorsMingyu Huo, Dan Li, Nan Li, et al.Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.Nature Reviews. Cancer|May 13, 2024
Cancer therapy with antibodiesSuman Paul, Maximilian F Konig, Drew M Pardoll, et al.Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.Pediatric Blood & Cancer|January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemiaNirali N Shah, Deepa Bhojwani, Keith August, et al.Nanomedicine (London, England)|May 2, 2015
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxelHirofumi Hanaoka, Takahito Nakajima, Kazuhide Sato, et al.Pageof 45